# GSK plc (GSK)

GSK's Blenrep drug receives FDA approval for specific patient groups, but faces scrutiny over label restrictions. The company is also actively pursuing strategic partnerships and acquisitions to bolster its pipeline.

### About GSK plc
GSK plc is a multinational pharmaceutical and biotechnology company.  
GSK plc uses the ticker $GSK for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- GSK plc (GSK) social dominance is up 114.75% from the previous week.

### Price: $58.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/close.tsv)  
The stock price is near a 52-week high, supported by positive news like the FDA approval of Blenrep and recent acquisitions. However, potential volatility exists due to Blenrep's label restrictions, which are a significant critical theme in social discussions.  

24-Hour: 0.67%
7-Day: -2.16%
30-Day: 22.21%

1-Year High: $60.20 on 2026-02-06  
1-Year Low: $33.60 on 2025-04-10  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/alt_rank.tsv)  
GSK plc (GSK) is currently AltRank #1,160 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +1,105  
[--] Month: [-----] +23  
[--] Months: [-----] +450  
[--] Year: [-----] +699  
1-Year High: [-----] on 2026-01-31  
1-Year Low: [--] on 2025-06-08  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +11  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-05-13  
1-Year Low: [--] on 2025-07-03  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [-------] -20%  
[--] Month: [-------] +80%  
[--] Months: [---------] -0.51%  
[--] Year: [---------] -2.60%  
1-Year High: [-------] on 2025-07-30  
1-Year Low: [---] on 2025-12-07  

Engagements by network (24h):
Reddit: [--]
YouTube: [--]
X: [-----]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] -5.90%  
[--] Month: [---] +67%  
[--] Months: [-----] -27%  
[--] Year: [-----] +56%  
1-Year High: [---] on 2025-08-03  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning GSK plc (GSK) in the last [--] hours which is down 18% from [---] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +1.90%  
[--] Month: [---] +86%  
[--] Months: [-----] -18%  
[--] Year: [-----] +58%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-12-07  

The most influential creators that mention GSK plc in the last [--] hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@JandTContent](/creator/twitter/JandTContent)     | [--]    | [-----]     | [--]    | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)         | [--]    | [--]        | [--]     | [---]         |
| [@MiraNunes70748](/creator/twitter/MiraNunes70748) | [--]    | [---]       | [--]     | [---]         |
| [@notdumbmoney](/creator/twitter/notdumbmoney)     | [--]    | [---]       | [--]     | [---]         |
| [@Yam_Trades](/creator/twitter/Yam_Trades)         | [--]    | [-----]     | [--]     | [---]         |
| [@VizFactTheDude](/creator/twitter/VizFactTheDude) | [--]    | [--]        | [--]     | [--]          |
| [@kinatsofrim](/creator/twitter/kinatsofrim)       | [--]    | [---]       | [--]     | [--]          |
| [@GSK](/creator/twitter/GSK)                       | [--]    | [-------]   | [--]     | [--]          |
| [@doepke_michel](/creator/twitter/doepke_michel)   | [--]    | [-----]     | [--]     | [--]          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)   | [--]   | [-----]     | [--]     | [--]          |

[View More](/list/creators/gsk-plc/100)
  
  
### Sentiment: 85%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/sentiment.tsv)  
Current Value: 85%  
Daily Average: 73%  
[--] Week: 67% -33%  
[--] Month: 83% +2%  
[--] Months: 83% +22%  
[--] Year: 83% +23%  
1-Year High: 100% on 2025-03-21  
1-Year Low: 37% on 2025-12-02  

Most Supportive Themes:
- FDA Approval of Blenrep: (30%) GSK's multiple myeloma drug Blenrep has received FDA approval for specific patient groups, marking a significant regulatory milestone.
- Partnerships and Acquisitions: (20%) GSK is actively engaging in strategic partnerships and acquisitions, such as the deal with Empirico, to expand its pipeline and market reach.
  
Most Critical Themes:
- Blenrep Label Restrictions: (40%) Despite FDA approval, Blenrep's label is narrower than anticipated, raising concerns about its near-term commercial upside and market penetration.
- Pipeline Development Challenges: (35%) GSK faces ongoing challenges in its R&D pipeline, with some drug candidates like the one partnered with Alector failing in late-stage trials.
  
  
  
### Social Dominance: 0.012%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/social_dominance.tsv)  
Current Value: 0.012%  
Daily Average: 0.02%  
[--] Week: 0.013% +0.007%  
[--] Month: 0.023% +0.011%  
[--] Months: 0.023% +0.0084%  
[--] Year: 0.023% -0.0094%  
1-Year High: 0.067% on 2025-08-03  
1-Year Low: 0.0024% on 2025-12-07  
  
  
### Market Dominance: 0.134%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/market_dominance.tsv)  
Current Value: 0.134%  
Daily Average: 0%  
1-Year High: 2.90% on 2025-03-31  
1-Year Low: 0.095% on 2025-07-21  
  
  
### Market Cap: $118,251,422,371
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/gsk-plc/time-series/market_cap.tsv)  
Current Value: $118,251,422,371  
Daily Average: $85,374,594,572  
[--] Week: $119,074,145,656 -1.20%  
[--] Month: $118,251,422,371 +19%  
[--] Months: $118,251,422,371 +50%  
[--] Year: $118,251,422,371 +60%  
1-Year High: $120,860,057,176 on 2026-02-06  
1-Year Low: $68,072,746,997 on 2025-04-10  

### Top GSK plc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"I think I am going at least half port $ETN $HCA $DE $SNDK $KLAC $ANET $MMC $MCO $APH $SHW $CDNS $NVO $ASML $BABA $AZN $TM $TWM $HSBC $RY $TD $SNY $UL $HMC $BP $SONY $BUD $RIO $GSK $MELI $EL $ZTS $DHR $SYK $ITW $VRTX $APD $ECL $ICE $ROP $WM $LHX $NOC $NSC $MPC $PSX $VLO $HWM $F INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET YET While most investors chase headlines the smart money inside Prairie Operating Co. has been quietly building massive positions. Key insiders control a significant chunk of the float Leadership and major holders own https://t.co/Y81oDJoJEm INSIDERS ARE LOADING $PROP WHY"  
[X Link](https://x.com/BuyTheUgly/status/2022403111005098454) [@BuyTheUgly](/creator/x/BuyTheUgly) 2026-02-13T20:10Z [--] followers, [---] engagements


"Los ms jvenes parecen elegir $HIMS. Estees algo que hablabamos una vez en la carrera. Uno de mis procesores trabaj en $GSK y nos comentaba que uno de los principales problemas que enfrentaban era el envejicimiento de sus clientes. Sus clientes estaban falleciendo. Younger generations are using $HIMS = Once they become loyal subscribers 📈 https://t.co/Ke9F7dtWYu Younger generations are using $HIMS = Once they become loyal subscribers 📈 https://t.co/Ke9F7dtWYu"  
[X Link](https://x.com/Seeking_Profits/status/2022365262062993588) [@Seeking_Profits](/creator/x/Seeking_Profits) 2026-02-13T17:40Z [---] followers, [---] engagements


"Exciting top-line results from Upstream Bio Inc.'s Phase [--] VALIANT Trial in Severe Asthma. 📈 $UPB #Biotech #TrialResults $UPST $BIIB $MRK $GSK $AZN https://notdumbmoney.com/upb/20260211141835 https://notdumbmoney.com/upb/20260211141835"  
[X Link](https://x.com/notdumbmoney/status/2022266945681121380) [@notdumbmoney](/creator/x/notdumbmoney) 2026-02-13T11:09Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing